Medical Cannabis Operators Face June 26 Deadline for DEA Registration

June 26 Deadline Triggers Expedited Review Window

Operators who submit DEA registration applications by June 26 will receive expedited review under the agency's interim medical cannabis framework. The Drug Enforcement Administration published the interim rule on March 15, 2026, establishing a 90-day window for businesses already operating under state medical cannabis licenses to apply for federal registration without entering the standard multi-year queue. Miss the deadline? Gullickson told MG Magazine that applicants will face the DEA's standard review timeline, which historically averages 18 to 24 months for Schedule III substances.

The expedited pathway applies to cultivators, processors, distributors, and dispensaries holding active state medical cannabis licenses as of the rule's effective date. Applicants must demonstrate compliance with state regulations for at least 12 consecutive months and submit fingerprint cards for all owners holding 10 percent or greater equity stakes.

Ownership Disclosures and Financial Records Under Federal Scrutiny

DEA registration requires disclosure of all beneficial owners, including passive investors and entities holding indirect stakes through holding companies. Many operators have structured ownership through layered LLCs to comply with state residency requirements or to accommodate out-of-state capital, Gullickson said, but the federal application demands a flattened org chart naming every individual with a financial interest. Cross-referencing is standard. The DEA checks applicant names against its database of prior controlled-substance violations, bankruptcy filings, and federal tax liens.

Financial documentation includes three years of audited or reviewed financial statements, proof of liability insurance with minimum coverage of two million dollars per occurrence, and bank statements showing segregated accounts for cannabis revenue. Operators using credit unions or state-chartered banks must provide letters from those institutions confirming the accounts remain open and in good standing.

Product Traceability and SOP Documentation Now Federal Requirements

The DEA requires applicants to submit standard operating procedures covering cultivation, processing, inventory control, waste disposal, and diversion prevention. Gullickson said the agency's reviewers focus on traceability — the ability to track every plant, batch, and finished unit from seed to sale. State track-and-trace systems such as Metrc or BioTrack satisfy the federal requirement only if the operator can produce complete chain-of-custody records for the prior 12 months without gaps or manual corrections.

Operators must demonstrate that their traceability systems can generate batch-level reports within 24 hours of a DEA audit request, a standard that exceeds most state requirements.

Security protocols must include video surveillance covering all limited-access areas with 90-day retention, intrusion-detection systems monitored by a licensed alarm company, and visitor logs recording entry and exit times for non-employees. Written policies are mandatory. The DEA also requires documentation for employee background checks, key control, and incident reporting.

What Operators Should Audit Before Filing

Gullickson recommended operators conduct internal readiness audits focusing on five areas: license validity, ownership transparency, product documentation, security compliance, and financial controls. License validity means confirming that state licenses carry no pending violations, fines, or conditional-approval riders. Ownership transparency requires mapping every investor, lender, and service provider with revenue-sharing agreements onto a single disclosure form. Product documentation means pulling a random sample of 50 batches from the past year and verifying that each has complete seed-to-sale records with no missing transfer manifests.

Security compliance audits should include a walkthrough with the alarm vendor to confirm that camera coverage matches the DEA's square-footage requirements and that video files are stored in a format the agency can review without proprietary software. Financial controls include verifying that cannabis revenue never commingles with non-cannabis funds and that the operator maintains separate ledgers for medical and adult-use sales where applicable.

For full background on this story, see the CannIntel topic hub on DEA Registration for Medical Cannabis.

The next signal: DEA will publish a list of approved registrants by September 30, 2026. Operators who filed by the June 26 deadline should expect preliminary decisions by mid-August.